Comerica Bank
ACOR

Comerica Bank’s Acorda Therapeutics ACOR Stock Holding History

Comerica Bank’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-389
Closed -$49K – 2304
2020
Q1 		$49K Buy
389
+17
+5% +$3.35K ﹤0.01% 2216
2019
Q4 		$95K Sell
372
-3
-0.8% -$757 ﹤0.01% 2240
2019
Q3 		$90K Buy
375
+69
+23% +$37.5K ﹤0.01% 2231
2019
Q2 		$253K Sell
306
-21
-6% -$25.8K ﹤0.01% 2131
2019
Q1 		$502K Buy
327
+8
+3% +$14.4K ﹤0.01% 1882
2018
Q4 		$597K Sell
319
-2
-0.6% -$4.35K 0.01% 1799
2018
Q3 		$702K Sell
321
-93
-22% -$288K 0.01% 1754
2018
Q2 		$1.47M Buy
414
+3
+0.7% +$9.19K 0.01% 1458
2018
Q1 		$1.15M Buy
411
+12
+3% +$35.9K 0.01% 1562
2017
Q4 		$1.3M Sell
399
-11
-3% -$31.3K 0.01% 1513
2017
Q3 		$1.34M Buy
410
+3
+0.7% +$7.9K 0.01% 1464
2017
Q2 		$1.09M Sell
407
-21
-5% -$41.6K 0.01% 1529
2017
Q1 		$799K Buy
428
+18
+4% +$51.8K 0.01% 1702
2016
Q4 		$1.05M Buy
410
+21
+5% +$49.9K 0.01% 1559
2016
Q3 		$966K Buy
389
+5
+1% +$14.9K 0.01% 1513
2016
Q2 		$1.11M Sell
384
-4
-1% -$13K 0.01% 1432
2016
Q1 		$1.33M Buy
388
+23
+6% +$95.5K 0.01% 1314
2015
Q4 		$1.76M Sell
365
-5
-1% -$21.9K 0.02% 1063
2015
Q3 		$1.18M Sell
370
-382
-51% -$1.48M 0.01% 1345
2015
Q2 		$3.01M Buy
752
+390
+108% +$1.51M 0.01% 1277
2015
Q1 		$1.45M Sell
362
-338
-48% -$1.55M 0.01% 1282
2014
Q4 		$3.43M Buy
700
+344
+97% +$1.48M 0.01% 1161
2014
Q3 		$1.45M Buy
356
+5
+1% +$18.8K 0.01% 1279
2014
Q2 		$1.42M Sell
351
-2
-0.6% -$8.15K 0.01% 1303
2014
Q1 		$1.6M Sell
353
-10
-3% -$40.4K 0.01% 1284
2013
Q4 		$1.27M Sell
363
-38
-9% -$148K 0.01% 1417
2013
Q3 		$1.65M Buy
401
+8
+2% +$34.5K 0.01% 1285
2013
Q2 		$1.55M Buy
+393
New +$1.62M 0.01% 1109

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Comerica Bank's ACOR Position: Q2 2020 in Review

Comerica Bank sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 389 shares — an estimated $49K sold.

Comerica Bank first reported a position in ACOR in Q2 2013 and held it in 28 quarters. The position peaked at $3.43M in Q4 2014. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • Comerica Bank reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Comerica Bank sold 389 Acorda Therapeutics shares in Q2 2020, an estimated $49K.
  • Comerica Bank first reported a position in Acorda Therapeutics in Q2 2013 and held it in 28 quarters.
  • Comerica Bank's Acorda Therapeutics position peaked at $3.43M in Q4 2014.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Comerica Bank's 13F filing for Q2 2020, filed 31 Jul 2020.